These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 33762213)
1. Senescence, immune microenvironment, and vascularization in cardiac myxomas. Karpathiou G; Dumollard JM; Camy F; Sramek V; Dridi M; Picot T; Mobarki M; Peoc'h M Cardiovasc Pathol; 2021; 52():107335. PubMed ID: 33762213 [TBL] [Abstract][Full Text] [Related]
2. Autophagy in cardiac myxoma: An important puzzle piece in understanding its inflammatory environment. Sramek V; Dridi M; Papoudou-Bai A; Dumollard JM; Péoc'h M; Karpathiou G Pathol Res Pract; 2021 Oct; 226():153609. PubMed ID: 34537518 [TBL] [Abstract][Full Text] [Related]
3. Innate immunity in cardiac myxomas and its pathological and clinical correlations. Di Vito A; Santise G; Mignogna C; Chiefari E; Cardillo G; Presta I; Arturi F; Malara N; Brunetti F; Donato A; Maisano D; Leonetti S; Maselli D; Barni T; Donato G Innate Immun; 2018 Jan; 24(1):47-53. PubMed ID: 29145790 [TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor and angiogenesis in cardiac myxoma: a study of fifteen patients. Kono T; Koide N; Hama Y; Kitahara H; Nakano H; Suzuki J; Isobe M; Amano J J Thorac Cardiovasc Surg; 2000 Jan; 119(1):101-7. PubMed ID: 10612767 [TBL] [Abstract][Full Text] [Related]
5. The role of tumor vascularisation in benign and malignant cardiovascular neoplasms: a comparison of cardiac myxoma and sarcomas of the pulmonary artery. Gaumann A; Strubel G; Bode-Lesniewska B; Schmidtmann I; Kriegsmann J; Kirkpatrick CJ Oncol Rep; 2008 Aug; 20(2):309-18. PubMed ID: 18636191 [TBL] [Abstract][Full Text] [Related]
6. Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma. Zhang T; Koide N; Wada Y; Tsukioka K; Takayama K; Kono T; Kitahara H; Amano J Circ J; 2003 Jan; 67(1):54-60. PubMed ID: 12520153 [TBL] [Abstract][Full Text] [Related]
7. Atrial myxoma: a tumour in search of its origins. Krikler DM; Rode J; Davies MJ; Woolf N; Moss E Br Heart J; 1992 Jan; 67(1):89-91. PubMed ID: 1531423 [TBL] [Abstract][Full Text] [Related]
8. Expression of tenascin-c and CD44 receptors in cardiac myxomas. Donato G; Conforti F; Zuccalà V; Russo E; Maltese L; Perrotta I; Amorosi A Cardiovasc Pathol; 2009; 18(3):173-7. PubMed ID: 18502153 [TBL] [Abstract][Full Text] [Related]
9. Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression. Jiang Z; Kang Q; Qian H; Xu Z; Tong H; Yang J; Li L; Li R; Li G; Chen F; Lin N; Zhao Y; Shi H; Huang J; Ma X Signal Transduct Target Ther; 2024 Aug; 9(1):193. PubMed ID: 39090109 [TBL] [Abstract][Full Text] [Related]
10. The role of mast cell tryptases in cardiac myxoma: Histogenesis and development of a challenging tumor. Donato G; Conforti F; Camastra C; Ammendola M; Donato A; Renzulli A Oncol Lett; 2014 Jul; 8(1):379-383. PubMed ID: 24959280 [TBL] [Abstract][Full Text] [Related]
11. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer. Zhang Y; Wang F; Sun HR; Huang YK; Gao JP; Huang H J Cancer Res Clin Oncol; 2021 Aug; 147(8):2209-2222. PubMed ID: 33891173 [TBL] [Abstract][Full Text] [Related]
12. Glandular cardiac myxomas. Histologic, immunohistochemical, and ultrastructural evidence of epithelial differentiation. Goldman BI; Frydman C; Harpaz N; Ryan SF; Loiterman D Cancer; 1987 May; 59(10):1767-75. PubMed ID: 2435400 [TBL] [Abstract][Full Text] [Related]
13. Histogenesis of cardiac myxomas. An immunohistochemical study of 19 cases, including one with glandular structures, and review of the literature. Johansson L Arch Pathol Lab Med; 1989 Jul; 113(7):735-41. PubMed ID: 2472783 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of cellular components of cardiac myxoma: a light microscopy and immunohistochemistry study. Deshpande A; Venugopal P; Kumar AS; Chopra P Hum Pathol; 1996 Oct; 27(10):1056-9. PubMed ID: 8892590 [TBL] [Abstract][Full Text] [Related]
15. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time. Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216 [TBL] [Abstract][Full Text] [Related]
16. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway. Lv Y; Zhao Y; Wang X; Chen N; Mao F; Teng Y; Wang T; Peng L; Zhang J; Cheng P; Liu Y; Kong H; Chen W; Hao C; Han B; Ma Q; Zou Q; Chen J; Zhuang Y J Immunother Cancer; 2019 Feb; 7(1):54. PubMed ID: 30808413 [TBL] [Abstract][Full Text] [Related]